Gene Transfer Vector Core (GTVC) Revenue

Hospitals and Health Care • Boston, Massachusetts, United States • 1-10 Employees

Gene Transfer Vector Core (GTVC) revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Gene Transfer Vector Core (GTVC)

Jiten Doshi

Associate Director

Company overview

Headquarters	20 Staniford St, Boston, Massachusetts 02114, US
Website	partners.org
NAICS	62
Keywords	AAV, Gene Therapy, Adeno-Associated Viral Vector
Founded	2013
Employees	1-10
Socials

About Gene Transfer Vector Core (GTVC)

Gene Transfer Vector Core The Gene Transfer Vector Core (GTVC) is a viral vector core facility located at the Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, both affiliated with Harvard Medical School. GTVC is an integral part of the Grousbeck Gene Therapy Center and the Ocular Genomics Institute of Harvard Medical School and Massachusetts Eye and Ear Infirmary. Our primary goal is to provide high titer, high quality research-grade viral vectors to the research community at Harvard, within Boston, and outside to support preclinical gene therapy studies and basic research gene transfer applications. Our Services Include: - High titer, high-quality research-grade Adeno-Associated viruses (AAV). - Production of customized vectors at different scales. - Inventory of ready-made reporter and commonly used gene vectors. - Consultation & assistance application-specific vector design. - Plasmid cloning and purification support services - High-quality full sequence analysis of source material

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Gene Transfer Vector Core (GTVC) has never raised funding before.

Frequently asked questions

Gene Transfer Vector Core (GTVC) is located in Boston, Massachusetts, US.

Gene Transfer Vector Core (GTVC) generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Gene Transfer Vector Core (GTVC) has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Gene Transfer Vector Core (GTVC) was founded in 2013, making it 13 years old. The company has established itself as a significant player in its industry over this time.

Gene Transfer Vector Core (GTVC) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Gene Transfer Vector Core (GTVC)

Jiten Doshi

Associate Director

4.8

40,000 users